This research indicates to me that the immunity from natural infection is adequate without later vaccination and at least as flexible when it comes to future variants. If quantitative antibody testing of recovered patients were being done to find (likely rare) cases of poor immune response, then subsequent vaccination might be scientifically sound. In the case of what is currently being practiced, I think the vaccines are just trying to hitch their wagon to a star.
https://www.nature.com/articles/s41586-021-03207-w#citeas
Evolution of antibody immunity to SARS-CoV-2
Gaebler, C., Wang, Z., Lorenzi, J.C.C.
et al. Evolution of antibody immunity to SARS-CoV-2.
Nature 591, 639–644 (2021).
https://doi.org/10.1038/s41586-021-03207-w
...
Memory B cells display clonal turnover after 6.2 months, and the antibodies that they express have greater somatic hypermutation, resistance to RBD mutations and increased potency, indicative of continued evolution of the humoral response. Immunofluorescence and PCR analyses of intestinal biopsies obtained from asymptomatic individuals at 4 months after the onset of coronavirus disease 2019 (COVID-19) revealed the persistence of SARS-CoV-2 nucleic acids and immunoreactivity in the small bowel of 7 out of 14 individuals.
We conclude that the memory B cell response to SARS-CoV-2 evolves between 1.3 and 6.2 months after infection in a manner that is consistent with antigen persistence.